Northwest Biotherapeutics, Inc. ( NWBO) - Stock Earnings
NWBO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
NWBO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -14.4 million USD | 201000 USD |
| 2023Q3 | -18.6 million USD | 406000 USD |
| 2023Q4 | -18.9 million USD | 445000 USD |
NWBO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 179.1 million USD | 1.0 million USD |
| 2022 | -105.0 million USD | 1.7 million USD |
| 2023 | -62.6 million USD | 1.9 million USD |
| 2026 Est. | — | — |
NWBO
Price: $0.19
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -3.73
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.3 million
Ebitda: -69.1 millionMarket Capitalization: 261.3 million